Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PRASTERONE for Atrophic vulvovaginitis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 214 adverse event reports in the FDA FAERS database where PRASTERONE was used for Atrophic vulvovaginitis.

Most Reported Side Effects for PRASTERONE

Side Effect Reports % Deaths Hosp.
Off label use 653 43.1% 0 15
Application site discharge 111 7.3% 0 1
Drug ineffective 105 6.9% 0 1
Vaginal discharge 82 5.4% 0 0
Vulvovaginal burning sensation 71 4.7% 0 0
Headache 59 3.9% 0 20
Rash 57 3.8% 0 33
Alopecia 55 3.6% 0 1
Product dose omission issue 55 3.6% 0 2
Therapeutic response unexpected 52 3.4% 0 0
Product administration error 47 3.1% 0 0
Underdose 45 3.0% 0 0
Insomnia 44 2.9% 0 1
Product physical issue 43 2.8% 0 0
Vaginal haemorrhage 43 2.8% 0 1

Other Indications for PRASTERONE

Product used for unknown indication (587) Vulvovaginal dryness (268) Dyspareunia (259) Vulvovaginal pain (37) Urinary tract infection (32) Menopause (31) Menopausal symptoms (24) Vulvovaginal discomfort (22) Vaginal disorder (19) Vulvovaginal burning sensation (17)

Other Drugs Used for Atrophic vulvovaginitis

ESTRADIOL (1,139) ESTROGENS, CONJUGATED (483) OSPEMIFENE (169) OSPHENA (25) PREMARIN (16) ESTRADIOL\NORETHINDRONE (11) ESTRING (11) ESTROGENS, CONJUGATED\MEDROXYPROGESTERONE (8) ESTRIOL (6) DUPILUMAB (5)

Related Pages

PRASTERONE Full Profile All Atrophic vulvovaginitis Drugs PRASTERONE Demographics PRASTERONE Timeline